360 Results (Page 12 of 15)
India Markets Research Reports
India Clinical Trial Equipments & Ancillary Solutions Market Analysis
India Clinical Trial Equipment & Ancillary Solutions Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2033. The market for Clinical Trial Equipment & Ancillary Solutions is expanding as a result of rising R&D expenditure in this sector. Increasing clinical trials, development in technology and increasing demand for personalized medicine are fueling the development of accurate clinical trial equipment and ancillary solutions market. Some of the key players in the global Clinical Trial Equipment & Ancillary Solutions Market include Thermo Fisher Scientific Inc., Covance Inc., LabCorp, Parexel International Corporation, PRA Health Sciences, Inc., ICON plc, Medpace Holdings, Inc., Syneos Health Inc., IQVIA Holdings Inc., Charles River Laboratories International, Inc.
India Clinical Trial Kits Market Analysis
India Clinical Trial Kits Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Clinical Trial Kits is expanding as a result of rising clinical trials, investment in Research & Development, and growing demand for remote services. Some of the key players in the global Clinical Trial Kits Market include Brooks Life Science, Q2 Solutions, Patheon (Thermo Fisher Scientific Inc), LabCorp Drug Development, Charles River Laboratories, LabConnect, Almac Group, Precision Medicine Group, Cerba Research, Alpha Laboratories, Marken, and Clinigen.
India Clinical Trial Packaging Market Analysis
India Clinical Trial Packaging Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Clinical Trial Packaging is expanding as a result of development of new drugs and an increase in research & development activities. Additionally, there is an increasing need for creative packaging solutions, which is encouraging the use of packaging materials that are more eco-friendly and can be recycled with ease. Such elements are fueling the expansion of the clinical trial packaging industry. Some of the key players in the global Clinial Trial Packaging Market include Bilcare, Fisher Clinical Services, Wuxi AppTec, PCI Pharma Services, Almac Group, PharMaterials, PAREXEL, The Coghlan Group, Xerimis Inc., Piramal Pharma Solutions, Sentry BioPharma, Sharp Packaging, Westrock, and Corden Pharma Gmbh.
India Clinical Trial Planning and Design service Market Analysis
India Clinical Trial Planning and Design Service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The market for Clinical Trial Planning and Design Service Market is growing due to rapid increase in technological advancements, growing collaboration, and surge of vendors in the market. Some of the key players in the global Clinical Trial Planning and Design Service Market include PharmsLex, Emergo UL, Cytel, Health Policy Associate, CD BioSciences, LLX Solutions, SGS, ADM Korea, ClinAsis, BioPoint, Atlantia Clinical Trials, IQVIA, and PPD, Inc.
India Clinical Trial Supply & Logistics for Pharmaceutical Market Analysis
India Clinical Trial Supply & Logistics for Pharmaceuticals Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The market for Clinical Trial Supply & Logistics for Pharmaceuticals Market is growing due to rapid increase in clinical trials, implementation of strict regulations, increase in research and development expenditure by pharmaceutical and biopharmaceutical firms, and advancements in technology. Some of the key players in the global Clinical Trial Supply & Logistics for Pharmaceuticals Market include Thermo Fisher Scientific (Patheon), Catalent, Inc., Parexel, Almac Group, Marken, Piramal Pharma Solutions, UDG Healthcare, DHL, FedEx, Movianto, and Packaging Coordinators Inc.
India Colorectal Cancer Diagnostic Market Analysis
India Colorectal Cancer Diagnostic Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Colorectal Cancer diagnostics is expanding as a result of increased research in pharmacological and biotechnology field and growing automation in laboratories. This demand is fueling the development of better diagnostic devices and methods for the early detection and accurate diagnosis of colorectal cancer. Some of the key players in the global Colorectal Cancer Diagnostics Market are F. Hoffmann-La Roche Ltd., Abbott., Illumina, QIAGEN, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Inc., Merck KGaA., Hologic, Inc., General Electric Company, Siemens Healthcare, Koninklijke Philips N.V., Beijing O&D Biotech Co., Ltd.
India Community Oncology service Market Analysis
India Community Oncology service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Community Oncology Services is expanding as a result of increasing prevalence of cancer in both developing and developed countries. Advancements in diagnostic devices and methods for cancer, treatment modalities and telemedicine are also driving the growth of Community Oncology service market globally. Some of the key players in the global Community Oncology Service Market McKesson Corporation, F. Hoffmann-La Roche AG, Novartis International AG, Bristol-Myers Squibb, Amgen Inc., Merck & Co., Inc., AstraZeneca plc, Pfizer Inc., Johnson & Johnson, and Eli Lilly and Company.
India Neurology Devices Market Analysis
India's neurology device market size was valued at $230 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 10.80% from 2022 to 2030 and will reach $521 Mn in 2030. The neurology device market in India is expected to grow in the coming years due to factors such as the increasing prevalence of neurological disorders, the availability of new technologies, and the growing healthcare expenditure in the country. The market is segmented by type of device and end user. The key players in the markets are B. Braun Melsungen AG, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC, and Nihon Kohden Corporation.
India HIV Therapeutics Market Analysis
By 2030, it is anticipated that the India HIV therapeutics market will reach a value of $389.90 Mn from $250.23 Mn in 2022, growing at a CAGR of 5.7% during 2022-2030. The market is primarily dominated by local players such as Cipla Limited, Aurobindo Pharma, and Hetero Drugs Limited. The market is driven by innovation in research and development, increasing prevalence, and good governance. The HIV therapeutics market in India is segmented by type, product, geography, end user, and distribution channel.
India Diabetes Therapeutics Market Analysis
India's diabetes therapeutics market is expected to grow from $2.61 Bn in 2022 to $6.81 Bn in 2030 with a CAGR of 12.7% for the forecasted year 2022-2030. The increasing awareness about diabetes and its consequences along with the rise in urbanization and improvement in healthcare infrastructure in India is responsible for the expansion of the market. The Indian diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Torrent Pharmaceuticals, Zydus Lifesciences, and GlaxoSmithKline are the major players in the Indian diabetes therapeutics market.
India Neurology Drugs Market Analysis
This report presents a strategic analysis of the India Neurology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India Neurology Drugs Market, offering unmatched value, accuracy and expert insights.
India Antibacterial (Antibiotics) Drugs Market Analysis
This report presents a strategic analysis of the India Antibacterial (Antibiotics) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India Antibacterial (Antibiotics) Drugs Market, offering unmatched value, accuracy and expert insights.
India Healthcare Reimbursement Market Analysis
This report presents a strategic analysis of the India Healthcare Reimbursement Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India Healthcare Reimbursement Market, offering unmatched value, accuracy and expert insights.
India Biosimilars Market Analysis
India's biosimilars market size was valued at $349 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 25.2% from 2022 to 2030 and will reach $2108 Mn in 2030. The market is segmented by product type and indication type. The Indian Biosimilars market will grow as India biosimilar market is driven by its cost-effective manufacturing capabilities. The key market players are Biocon Ltd (IND), Intas Pharmaceuticals Ltd (IND), Dr. Reddy's Laboratories Ltd (IND), Reliance Life Sciences Pvt. Ltd (IND), Zydus Cadila Healthcare Ltd (IND), Lupin Limited (IND)and others.
India Gastrointestinal Drugs Market Analysis
This report presents a strategic analysis of the India Gastrointestinal Drugs Market Analysis and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India Gastrointestinal Drugs Market Analysis, offering unmatched value, accuracy, and expert insights.
India Retail Pharmacy Market Analysis
India's retail pharmacy market is projected to grow from $18.89 Bn in 2022 to $40.19 Bn by 2030, registering a CAGR of 9.9% during the forecast period of 2022-2030. India's economic growth also contributes to market growth, as a growing economy leads to increased disposable income and investment in healthcare services. The retail pharmacy market in India is highly competitive, with several large players dominating the market, including Apollo Pharmacy, Medplus, and Healthkart.
India Women's Health Market Analysis
India's women’s health market is projected to grow from $0.726 Bn in 2022 to $1.325 Bn by 2030, registering a CAGR of 7.80% during the forecast period of 2022-2030. The increasing number of working women in India is driving the women's health market as they have more disposable income and need health care services. Some key players in the India Women's Health market include Apollo Hospitals, Manipal, and Medanta.
India 3D Imaging Market Analysis
India's 3D imaging market is projected to grow from $ 0.55 Bn in 2022 to $ 2.30 Bn by 2030, registering a CAGR of 19.5% during the forecast period of 2022-30. The market will be driven by increasing healthcare spending and positive government initiatives. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Philips Healthcare.
India ECG Equipments Market Analysis
The India ECG Equipment Market is expected to witness growth from $162 Mn in 2022 to $355 Mn in 2030 with a CAGR of 10.30% for the forecasted year 2022-2030. India has a high rate of heart attacks and arrhythmias, which is increasing the demand for ECG devices. The market is segmented by product type and by the end user. Some key players in this market include BPL Medical Technologies, Schiller India, Johnson & Johnson, Philipps Healthcare, Medtronic, Biolight and Dexcom.
India Dental Care Market Analysis
India's dental care market was valued at $653 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.40% from 2022 to 2030 and will reach $1339 Mn in 2030. One of the main reasons propelling the growth of this market is the rising knowledge and awareness among individuals regarding dental aids and various treatments that aim to improve personal health and hygiene. Some key players in this market are Clove Dental, 3M, Dentsply Sirona, GE Healthcare, and Philips Healthcare.
India Depression Therapeutics Market Analysis
The India depression therapeutics market is expected to witness growth from $184 Mn in 2022 to $345 Mn in 2030 with a CAGR of 8.2% for the forecasted year 2022-2030. The increasing investments in research and development projects for depression in India along with supportive government policies are responsible for the growth of the market. The Indian depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Mediwin Pharmaceuticals, Zydus Cadila, and GlaxoSmithKline are the major players in the Indian depression therapeutics market.
India Biomaterials in Healthcare Market Analysis
The India Biomaterials Healthcare Market is expected to witness growth from $2.84 Bn in 2022 to $9.44 Bn in 2030 with a CAGR of 16.20% for the forecasted year 2022-2030. India's large and ageing population increases its susceptibility to serious illnesses including osteoarthritis and cardiovascular disease, which usually require the use of biomaterials as a therapy, leading to the growth of the country's biomaterial healthcare industry. The market is segmented by type and by application. Some key players in this market include Poly Medicure, Sahajanand Medical Technologies, MicroPort, BASF SE, Celanese, Covestro AG and Evonik Industries.
India Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the India liver cancer therapeutics market will reach a value of $238.4 Mn from $53.3 Mn in 2022, growing at a CAGR of 20.6% during 2022-30. The liver cancer therapeutics in India is dominated by a few domestic pharmaceutical companies such as Dr. Reddy's Laboratories, HCG Hospitals, and Natco Pharma. The liver cancer therapeutics market in India is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
India Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the India Lung Cancer Therapeutics Market will reach a value of $1259 Mn from $542 Mn in 2022, growing at a CAGR of 11.1% during 2022-2030. The Lung Cancer Therapeutics Market in India is dominated by a few domestic pharmaceutical companies such as Lupin, Cipla, and Biocon. The Lung Cancer Therapeutics Market in India is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Indian lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
India Anti Aging Therapeutics Market Analysis
India anti-aging therapeutics market is expected to witness growth from $11 Mn in 2022 to $46 Mn in 2030 with a CAGR of 19.53% for the year 2022-2030. The growth from the baby boomer population to the middle age population in India and their subsequent demand for ant-aging products for a more youthful appearance are the major market drivers. The India anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Glenmark, Navitor Pharmaceuticals, and NeuroTrack are some of the key players in the market.
